Dr. Imberty is a senior researcher of Centre National de la Rercherche Scientifique, in the Institute (CERMAV), in Grenoble. She has been the director of CERMAV for the period 2016-2020 and chair of the Glyco@Alps network funded by Université Grenoble Alpes.

She graduated in biology from Ecole Normale Supérieure in Paris. In 1984, she joined the Centre National de la Recherche Scientifique in Grenoble and did her PhD on starch structure. She started modeling studies of protein-carbohydrate interaction during her post-doc in Toronto. Since 1999 she has a senior research position in CNRS-Grenoble. Her research interests are in the field of structural glycosciences, with main interest on biologically active oligosaccharides and their interaction with proteins. Her present work is focused about lectins from pathogenic microorganisms. The characterisation of their interaction with human glycoconjugates and the design of competing glycocompounds open the way for anti-adhesive therapeutical strategies. Furthermore, these lectins can be engineered through synthetic glycobiology strategy for creating new tools in biotechnology, diagnostics and therapy.

She received many awards, including the Young Researcher Award of the French Carbohydrate Society in 1999, the Roy Whistler Award from International Carbohydrate Organisation in 2004, the Catalán-Sabatier International Prize from the Spanish Royal Society of Chemistry in 2020 and the Rosalind Kornfeld award from the Society of Glycobiology in 2022. She published more than 300 scientific paper, she is Associate Editor of Glycobiology and will be co-chairing the next Glycobiology Gordon Research Conference in 2025.